Toumai® endoscopic robot-assisted thoracic surgery in three patients
- VernacularTitle:国产图迈®微创机器人辅助胸腔镜手术三例
- Author:
Dacheng JIN
1
,
2
;
Baiqiang CUI
1
,
2
;
Ning YANG
1
,
2
;
Xiaoyang HE
1
,
2
;
Yunjiu GOU
1
,
2
Author Information
1. Department of Thoracic Surgery, Gansu Province People&rsquo
2. s Hospital, Lanzhou, 730000, P. R. China
- Publication Type:Journal Article
- Keywords:
Domestic surgical robot;
Toumai® minimally invasive endoscopic surgical robot;
radical lung cancer surgery;
mediastinal tumor resection
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2022;29(04):524-528
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the application of Toumai® minimally invasive endoscopic robot in thoracic surgery, and to observe its safety and short-term surgical efficacy. Methods Three patients were enrolled from October to December 2021, including 1 male (69 years) and 2 females (47 years and 22 years). All 3 patients received surgery with Toumai® endoscopic surgical robot, including radical lung cancer surgery in 2 patients and mediastinal tumor resection in 1 patient. Results All 3 patients were successfully operated without conversion to thoracotomy, complication or death. For the male lobectomy patient, the total operation time was 120 min, the intraoperative blood loss was 100 mL, the catheter drainage time was 4 days and the hospital stay time was 5 days. For the female lobectomy patient, the total operation time was 103 min, the intraoperative blood loss was 100 mL, the catheter drainage time was 4 days and the hospital stay time was 5 days. For the female mediastinal tumor patient, the total operation time was 81 min, the intraoperative blood loss was 50 mL, the catheter drainage time was 3 days and the hospital stay time was 3 days. Conclusion The Toumai® minimally invasive endoscopic surgical robot is safe and effective in thoracic surgery. Compared with Da Vinci surgical robot, Toumai® has the same 3D visual field experience and smooth operation.
